These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1783112)

  • 1. Studies of lotus-extracted haptoglobin in inflammatory bowel disease.
    Thompson S; Record CO; Turner GA
    Biochem Soc Trans; 1991 Aug; 19(3):264S. PubMed ID: 1783112
    [No Abstract]   [Full Text] [Related]  

  • 2. A multiwell lectin-binding assay using lotus tetragonolobus for measuring different glycosylated forms of haptoglobin.
    Thompson S; Stappenbeck R; Turner GA
    Clin Chim Acta; 1989 Apr; 180(3):277-84. PubMed ID: 2743580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.
    Thompson S; Turner GA
    Br J Cancer; 1987 Nov; 56(5):605-10. PubMed ID: 3426924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral indices of disease activity in inflammatory bowel disease.
    Koldkjaer O; Klitgaard NA; Schmidt KG
    Digestion; 1978; 17(5):387-95. PubMed ID: 680416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA
    Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of serum mucoprotein with serum alpha 1 acid glycoprotein, haptoglobin, and alpha 1 antitrypsin assays in monitoring inflammatory bowel disease.
    Lubega J; Davies TJ
    Clin Chim Acta; 1990 Apr; 188(1):59-69. PubMed ID: 2347083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease].
    Vucelić B; Milicić D; Krznarić Z; Korać B; Sentić M; Hadzić N; Stavljenić A; Cvorisćec D
    Acta Med Austriaca; 1991; 18(4):100-5. PubMed ID: 1722373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of charcteristic protein fraction in serum of patients with Crohn's disease using polyacrylamide electrophoresis].
    Förster E; Meyer zum Büschenfelde ; Bierbach H; Holldorf AW
    Verh Dtsch Ges Inn Med; 1973; 79():851-3. PubMed ID: 4790021
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum carcinoembryonic antigen in clinical disorders.
    Booth SN; King JP; Leonard JC; Dykes PW
    Gut; 1973 Oct; 14(10):794-9. PubMed ID: 4758660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis.
    Weeke B; Jarnum S
    Gut; 1971 Apr; 12(4):297-302. PubMed ID: 4102485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient galactosylation of serum IgG in inflammatory bowel disease: correlation with disease activity.
    Go MF; Schrohenloher RE; Tomana M
    J Clin Gastroenterol; 1994 Jan; 18(1):86-7. PubMed ID: 8113595
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma fibronectin in inflammatory bowel disease].
    Kikuchi T; Hiwatashi N; Goto Y
    Nihon Shokakibyo Gakkai Zasshi; 1985 Apr; 82(4):599-602. PubMed ID: 4021164
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated factor XI and tissue factor in inflammatory bowel disease.
    Undas A; Owczarek D; Gissel M; Salapa K; Mann KG; Butenas S
    Inflamm Bowel Dis; 2010 Sep; 16(9):1447-8. PubMed ID: 20049947
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
    Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
    Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood leukocytes and T-lymphocytes in inflammatory bowel disease.
    Sategna-Guidetti C; Rutigliano AR
    Acta Gastroenterol Belg; 1979; 42(7-8):247-56. PubMed ID: 317692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinogen values in the development of active inflammatory diseases of the intestines].
    Petrović M
    Vojnosanit Pregl; 1980; 37(6):454-7. PubMed ID: 7210586
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastrointestinal hormones in inflammatory bowel disease.
    Spence RA; Wilson W; Alam MJ; Ardill JE; Buchanan KD; Merrett JD
    J R Coll Surg Edinb; 1983 Sep; 28(5):313-7. PubMed ID: 6644644
    [No Abstract]   [Full Text] [Related]  

  • 18. [Haptoglobin polymorphism in patients with inflammatory bowel diseases].
    Papp M; Lakatos PL; ; Palatka K; Földi I; Udvardy M; Hársfalvi J; Tornai I; Vitális Z; Dinya T; Kovács A; Molnár T; Demeter P; Papp J; Lakatos L; Altorjay I
    Orv Hetil; 2006 Sep; 147(36):1745-50. PubMed ID: 17087019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum gastrin in inflammatory bowel disease.
    Spence RA; Buchanan KD
    N Engl J Med; 1982 Dec; 307(24):1530. PubMed ID: 7144831
    [No Abstract]   [Full Text] [Related]  

  • 20. The glycosylation of haptoglobin in rheumatoid arthritis.
    Thompson S; Dargan E; Griffiths ID; Kelly CA; Turner GA
    Clin Chim Acta; 1993 Oct; 220(1):107-14. PubMed ID: 8287554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.